Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LIVN | Ordinary Shares | Options Exercise | $3.25M | +56.6K | +205.65% | $57.39 | 84.2K | Jun 3, 2024 | Direct | F1 |
transaction | LIVN | Ordinary Shares | Sale | -$3.28M | -54.6K | -64.85% | $60.08 | 29.6K | Jun 3, 2024 | Direct | F2, F3 |
transaction | LIVN | Ordinary Shares | Sale | -$125K | -2.05K | -6.91% | $61.09 | 27.5K | Jun 3, 2024 | Direct | F2, F4 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LIVN | Option to purchase shares | Options Exercise | $0 | -56.6K | -100% | $0.00* | 0 | Jun 3, 2024 | Ordinary Shares | 56.6K | $57.39 | Direct | F1, F5 |
Id | Content |
---|---|
F1 | The exercise of the option occurred pursuant to a Rule 10b5-1 Plan adopted by reporting person on May 25, 2021. |
F2 | The sale of the ordinary shares occurred pursuant to a Rule 10b5-1 Plan adopted by reporting person on May 25, 2021. |
F3 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.75 to $60.610, inclusive. The reporting person undertakes to provide to LivaNova PLC, any security holder of LivaNova PLC, or the staff of the Securities and Exchange Commission, upon request, the information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
F4 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.829 to $61.290, inclusive. The reporting person undertakes to provide to LivaNova PLC, any security holder of LivaNova PLC, or the staff of the Securities and Exchange Commission, upon request, the information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
F5 | The Form 3 filed on behalf of the reporting person on October 22, 2015 contained a typo in the expiration date for this option. This option expires on June 15, 2024. |